Asymmetrical dimethylarginine - The Uber marker?

被引：343
作者：
Cooke, JP [1 ]
机构：
[1] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA
来源：
CIRCULATION | 2004年 / 109卷 / 15期
关键词：
arginine; nitric oxide synthase; endothelium; risk factors; amidohydrolases;
D O I：
10.1161/01.CIR.0000126823.07732.D5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1813 / 1818
页数：6
相关论文
共 82 条
[1]   Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus [J].
Abbasi, F ;
Asagmi, T ;
Cooke, JP ;
Lamendola, C ;
McLaughlin, T ;
Reaven, GM ;
Stuehlinger, M ;
Tsao, PS .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (10) :1201-+
[2]   Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase [J].
Achan, V ;
Broadhead, M ;
Malaki, M ;
Whitley, G ;
Leiper, J ;
MacAllister, R ;
Vallance, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) :1455-1459
[3]   all-trans-retinoic acid increases nitric oxide synthesis by endothelial cells -: A role for the induction of dimethylarginine dimethylaminohydrolase [J].
Achan, V ;
Tran, CTL ;
Arrigoni, F ;
Whitley, GSJ ;
Leiper, JM ;
Vallance, P .
CIRCULATION RESEARCH, 2002, 90 (07) :764-769
[4]   Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease [J].
Adams, MR ;
McCredie, R ;
Jessup, W ;
Robinson, J ;
Sullivan, D ;
Celermajer, DS .
ATHEROSCLEROSIS, 1997, 129 (02) :261-269
[5]   Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction [J].
Al Suwaidi, J ;
Hamasaki, S ;
Higano, ST ;
Nishimura, RA ;
Holmes, DR ;
Lerman, A .
CIRCULATION, 2000, 101 (09) :948-954
[6]   Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia [J].
Arrigoni, FI ;
Vallance, P ;
Haworth, SG ;
Leiper, JM .
CIRCULATION, 2003, 107 (08) :1195-1201
[7]   Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes [J].
Asagami, T ;
Abbasi, F ;
Stuelinger, M ;
Lamendola, C ;
McLaughlin, T ;
Cooke, JP ;
Reaven, GM ;
Tsao, PS .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (07) :843-846
[8]   Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall, and intimal hyperplasia in perimenopausal human uterine arteries [J].
Beppu, M ;
Obayashi, S ;
Aso, T ;
Goto, M ;
Azuma, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 39 (02) :192-200
[9]   Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia [J].
Böger, RH ;
Bode-Böger, SM ;
Szuba, A ;
Tsao, PS ;
Chan, JR ;
Tangphao, O ;
Blaschke, TF ;
Cooke, JP .
CIRCULATION, 1998, 98 (18) :1842-1847
[10]   An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes [J].
Böger, RH ;
Bode-Böger, SM ;
Tsao, PS ;
Lin, PS ;
Chan, JR ;
Cooke, JP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2287-2295
123456789